Skip to main content
. Author manuscript; available in PMC: 2015 Apr 6.
Published in final edited form as: Med Oncol. 2014 Sep 27;31(11):254. doi: 10.1007/s12032-014-0254-7

Table 2.

The relationships between LRAT promoter methylation status and clinical features in CRCs

Tumor (CpG 1–6)
p value Adjacent normal (CpG 1–6)
p value
Hypermethylated Unmethylated Hypermethylated Unmethylated
Location
 Distal 39 42   5 32
 Proximal 20 22 0.96   7 25 0.36
Gender
 Male 29 30   4 29
 Female 30 34 0.8 11 25 0.06
Age
 <55   8 20   0 15
 55–64 17 13   4 13
 65–70 14 13   2 11
 71–85 20 18 0.13   6 18 0.07
AJCC stage
 I 12   8
 II 17   8
 III 15 18
 IV 15 30 0.03
Differentiation
 Well   0   1
 Moderate 48 52
 Poor   7   5
 No info   4   6 0.73
Mucinous histology
 No 37 47
 Yes 18 12
 No info   4   5 0.32
Mutations
 K-ras 23 18
 B-raf   3   2
 WT 33 44 0.31